Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom-Reference-Cited by-同舟云学术

Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

Published:2022-01-10 Issue:1 Volume:5 Page:e2142780
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Satukijchai Chanjira¹²³,Mariano Romina¹,Messina Silvia¹⁴,Sa Mario⁵,Woodhall Mark R.¹,Robertson Neil P.⁶,Ming Lim⁷⁸,Wassmer Evangeline⁹¹⁰,Kneen Rachel¹¹,Huda Saif¹²,Jacob Anu¹²¹³,Blain Camilla¹⁴,Halfpenny Christopher¹⁵,Hemingway Cheryl¹⁶,O'Sullivan Eoin¹⁷,Hobart Jeremy¹⁸¹⁹,Fisniku Leonora K.²⁰²¹,Martin Roswell²²,Dopson Ruth²³²⁴,Cooper Sarah A.²⁰,Williams Victoria²⁵,Waters Patrick J.¹,Ramdas Sithara²⁶,Leite Maria Isabel¹⁴,Palace Jacqueline¹⁴

Affiliation:

1. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom

2. Neuroscience Center, Bangkok International Hospital, Bangkok, Thailand

3. Division of Neurology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

4. Department of Clinical Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, United Kingdom

5. Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom

6. Department of Neurology, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Cardiff, United Kingdom

7. Children’s Neurosciences, Evelina London Children’s Hospital at Guy’s and St Thomas’ National Health Service Foundation Trust, London, United Kingdom

8. Department of Women and Children’s Health, School of Life Course Sciences, King’s College London, United Kingdom

9. Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, United Kingdom

10. School of Life and Health Sciences, Aston University, Birmingham, United Kingdom

11. Alder Hey Children's National Health Service Foundation Trust, Liverpool, United Kingdom

12. Department of Neurology, Walton Centre National Health Service Foundation Trust, Liverpool, United Kingdom

13. Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

14. St George’s University Hospitals National Health Service Foundation Trust, London, United Kingdom

15. University Hospitals Southampton National Health Service Foundation Trust, Southampton, United Kingdom

16. Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom

17. Department of Ophthalmology, Kings College Hospital, London, United Kingdom

18. Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom

19. University Hospitals Plymouth National Health Service Foundation Trust, United Kingdom

20. University Hospitals Sussex National Health Service Foundation Trust, Brighton, United Kingdom

21. Brighton and Sussex Medical School, Brighton, United Kingdom

22. Gloucestershire Hospitals National Health Service Foundation Trust, Gloucestershire, United Kingdom

23. Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, United Kingdom

24. Royal London Hospital, Barts Health National Health Service Foundation Trust, United Kingdom

25. Guy’s and St Thomas’ National Health Service Foundation Trust, London, United Kingdom

26. Department of Paediatric Neurology, John Radcliffe Hospital, Oxford, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2787769/satukijchai_2022_oi_211189_1646749435.32707.pdf

Reference26 articles.

1. The spectrum of MOG autoantibody-associated demyelinating diseases.;Reindl;Nat Rev Neurol,2013

2. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.;Jurynczyk;Brain,2017

3. Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.;Kaneko;J Neurol Neurosurg Psychiatry,2016

4. Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort.;Ketelslegers;Mult Scler,2015

5. Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.;Spadaro;Neurol Neuroimmunol Neuroinflamm,2016

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Simple Score (MOG-AR) to Identify Individuals at High Risk of Relapse After MOGAD Attack;Neurology Neuroimmunology & Neuroinflammation;2024-11

2. Study of seasonality of attacks in MOG antibody-associated disease;Multiple Sclerosis and Related Disorders;2024-10

3. The influence of MOGAD on diagnosis of multiple sclerosis using MRI;Nature Reviews Neurology;2024-09-03

4. Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease;JAMA Neurology;2024-09-03

5. Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults;Neurology;2024-08-13